
HYFT Market Capitalization Overview
Market Cap: $96.66M as of Jan 16, 2026
$96.66M
$20.08M (26.22%)past month
As of Jan 16, 2026, HYFT has a market capitalization of $96.66M. Over the past 30 days, its market cap has increased by 11.66%, while in the last 12 months, it has increased by 13.74%.
Market capitalization represents the total value of ImmunoPrecise Antibodies Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
HYFT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of HYFT helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of ImmunoPrecise Antibodies Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
HYFT Market Cap Formula = Stock Price * Shares Outstanding
The market cap of HYFT helps investors assess the company's size and compare it with competitors for better investment decisions.
HYFT Market Cap & Key Trends
See ImmunoPrecise Antibodies Ltd’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in HYFT
Order type
Buy in
Order amount
Est. shares
0 shares
HYFT Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Dec 1, 2025 | $84.47M | +3.98% |
| Nov 3, 2025 | $81.24M | -1.12% |
| Oct 1, 2025 | $82.16M | -7.77% |
| Sep 2, 2025 | $89.08M | +17.68% |
| Aug 1, 2025 | $75.70M | +51.74% |
| Jul 1, 2025 | $49.89M | +250.11% |
| Jun 2, 2025 | $14.25M | +23.57% |
| May 1, 2025 | $11.54M | +28.27% |
| Apr 1, 2025 | $8.99M | +9.51% |
| Mar 3, 2025 | $8.21M | -25.35% |
| Feb 3, 2025 | $10.99M | -2.00% |
| Jan 2, 2025 | $11.23M | +19.68% |
HYFT End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $96.66M | +13.74% |
| 2025 | $84.98M | +727.77% |
| 2024 | $10.27M | -75.92% |
| 2023 | $42.64M | -67.18% |
| 2022 | $129.92M | +24.74% |
| 2021 | $104.15M | — |
FAQs About ImmunoPrecise Antibodies Ltd (HYFT) Market Cap
As of Jan 16, 2026, the market capitalization of HYFT is $96.66M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, ImmunoPrecise Antibodies Ltd’s market capitalization has increased by 26.22%, changing from $76.58M to $96.66M as of Jan 16, 2026.
In the last 3 months, ImmunoPrecise Antibodies Ltd’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, ImmunoPrecise Antibodies Ltd’s market capitalization increased from $10.27M in January to $84.98M in December, reflecting a 727.77% change.
In the past five years, HYFT has had a compound annual growth rate (CAGR) of -3.99% in market capitalization. This means its market cap has shrunk at an average rate of -3.99% per year.